Eric O’Brien

Cincinnati Children's Hospital Medical Center

Also affiliated with University of Cincinnati

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting AML-associated FLT3 mutations with a type I kinase inhibitor”.

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor

Journal of Clinical Investigation(2020)10.1172/jci127907

N/A

0DataRank · unranked

39 citations

Katelyn Melgar, Lyndsey Bolanos, Kathleen Hueneman, Morgan M. Walker, Jian-kang Jiang +15 more

PD-1 Inhibition Enhances Blinatumomab Response in a UCB/PDX Model of Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia

Frontiers in Oncology(2021)10.3389/fonc.2021.642466

N/A

0DataRank · unranked

28 citations

Nicole Manning, Christina Sexton, Eric O’Brien, Luke Byerly, Cody Stillwell +4 more

PDX models of relapsed pediatric AML preserve global gene expression patterns and reveal therapeutic targets

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.31.478534

N/A

0DataRank · unranked

7 citations

Jing Chen, Christina Sexton, Nicole Manning, Luke Byerly, Eric O’Brien +4 more